1-4 of 4
Michael Fournel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of PEG-FVIII Molecules with Prolonged Half-Lives in a Murine FVIII-Dependent Bleeding Model.

Kyle A. Landskroner, Zhi-Hua Cui, James Newgren, Michael Fournel, Glenn F. Pierce, Gary J. Jesmok
Journal: Blood
Blood (2006) 108 (11): 1624.
https://doi.org/10.1182/blood.V108.11.1624.1624
Published: 2006
Journal Articles

Towards a New Therapy for Hemophilia A: Evaluation of Multiple Approaches To Prolong the In Vivo Efficacy of Recombinant Factor VIII.

John E. Murphy, Clark Pan, Baisong Mei, Jonathan Strauss, Hendri Tjandra, Liang Tang, Pamela Esmon, James Newgren, Gary Jesmok, Kyle Landskroner, Mohan Parmathi, Klaus-Peter Radtke, Joanne Severs, John Teare, Haiyan Jiang, Michael Fournel
Journal: Blood
Blood (2006) 108 (11): 1606.
https://doi.org/10.1182/blood.V108.11.1606.1606
Published: 2006
Journal Articles

A Pharmacologic Evaluation of BAY 79-4980 (Liposome-Formulated Kogenate® FS) in the Hemophilia A Mouse.

Gary Jesmok, Zhi-Hua Cui, Deogracias Canivel, Michael Fournel, Glenn Pierce, Kyle Landskroner
Journal: Blood
Blood (2006) 108 (11): 4003.
https://doi.org/10.1182/blood.V108.11.4003.4003
Published: 2006
Journal Articles

PEGylation of Factor VIII Reduces the Inhibitory Effects of Human Antibody Inhibitors on the Factor VIII Molecule.

Liang Tang, Clark Pan, Harpartap Atwal, Jennifer Nixon, Thomas Barnett, John E. Murphy, Baisong Mei, Michael Fournel
Journal: Blood
Blood (2006) 108 (11): 4017.
https://doi.org/10.1182/blood.V108.11.4017.4017
Published: 2006